SEC Company Response from Scinai Immunotherapeutics Ltd. (SCNI) (CIK 0001611747) (SCNI) — Apr 24, 2015
Scinai Immunotherapeutics Ltd. (SCNI) (CIK 0001611747)
Date: April 24, 2015 · CIK: 0001611747 · Accession: 0001213900-15-002989
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-201283
Letter
Attention: Matthew Jones Registration Statement on Form F-1 Filed April 8, 2015 File No. 333-201283
Re: Biondvax Pharmaceuticals Ltd.
Dear Mr. Jones:
BiondVax Pharmaceuticals Ltd. (the “Company”) hereby requests acceleration of the effective date of the above-referenced Registration Statement so that such Registration Statement shall become effective on April 28, 2015, at 5:00 p.m., Eastern Daylight Time, or as soon thereafter as is practicable.
The Company hereby acknowledges that:
● should the Securities and Exchange Commission (the “Commission”) or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;
● the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
● the Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Very truly yours,
/s/ Ron Babecoff
Show Raw Text
CORRESP
1
filename1.htm
April 24, 2015
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549-4561
Attention: Matthew Jones
Re: Biondvax Pharmaceuticals Ltd.
Registration Statement on Form
F-1
Filed April 8, 2015
File No. 333-201283
Dear Mr. Jones:
BiondVax Pharmaceuticals Ltd. (the “Company”)
hereby requests acceleration of the effective date of the above-referenced Registration Statement so that such Registration Statement
shall become effective on April 28, 2015, at 5:00 p.m., Eastern Daylight Time, or as soon thereafter as is practicable.
The Company hereby acknowledges that:
● should the Securities and Exchange Commission (the “Commission”) or
the staff,
acting
pursuant to
delegated authority,
declare
the filing effective,
it does not
foreclose the Commission
from taking
any
action
with respect to the
filing;
● the action of
the Commission or
the staff, acting
pursuant to
delegated
authority,
in declaring
the filing effective,
does not relieve
the Company
from its full responsibility
for the adequacy
and accuracy
of the disclosure
in the
filing; and
● the Company
may not assert
staff comments
and the declaration
of effectiveness
as a defense in
any
proceeding
initiated
by the Commission
or any
person under
the federal
securities
laws of the
United States.
Very truly yours,
/s/ Ron Babecoff
Ron Babecoff
Chief Executive Officer